| Line Item | 2022-07-31 | Y/Y |
|---|---|---|
| Revenue | $1.09B | +62.1% |
| Cost of Revenue | $242.3M | +61.2% |
| Gross Profit | $848.7M | +62.3% |
| R&D Expense | $289.1M | +65.6% |
| SG&A Expense | $151.7M | +57.2% |
| Operating Income | -$327.4M | -57.6% |
| Interest Expense | $56.6M | +6.0% |
| Pre-tax Income | -$383.6M | -49.2% |
| Income Tax | $6.6M |
| Line Item | 2022-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.01B | +267.2% |
| Accounts Receivable | $399.7M | +55.5% |
| Current Assets | $2.26B | +22.1% |
| Total Assets | $2.83B | +25.5% |
| Current Liabilities | $1.13B | +57.5% |
| Long-term Debt | $968.7M | +6.0% |
| Total Liabilities | $2.26B | +30.7% |
| Line Item | 2022-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $321.9M | +59.3% |
| Capital Expenditures | $69.3M | +43.9% |
| Investing Cash Flow | $374.1M | +441.1% |
| Financing Cash Flow | $41.3M | -0.8% |
| Free Cash Flow | $252.6M | +64.2% |
| +37.0% |
| Net Income | -$390.3M | -48.9% |
| EPS (Basic) | -$2.77 | -43.5% |
| EPS (Diluted) | -$2.77 | -43.5% |
| Stockholders' Equity |
| $573.3M |
| +8.4% |